Beck Bode’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Beck Bode's IBB Position: Q3 2026 in Review
Beck Bode sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 1,350 shares — an estimated $257K sold.
Beck Bode first reported a position in IBB in Q3 2022 and held it in 16 quarters. The position peaked at $2.09M in Q4 2022. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Beck Bode reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
- Beck Bode sold 1,350 iShares Biotechnology ETF shares in Q3 2026, an estimated $257K.
- Beck Bode first reported a position in iShares Biotechnology ETF in Q3 2022 and held it in 16 quarters.
- Beck Bode's iShares Biotechnology ETF position peaked at $2.09M in Q4 2022.
- 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.